These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 21757260)

  • 1. [Urinary tract infections and their prevention].
    González-Chamorro F; Palacios R; Alcover J; Campos J; Borrego F; Dámaso D
    Actas Urol Esp; 2012 Jan; 36(1):48-53. PubMed ID: 21757260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of E. coli adhesiveness in the pathogenesis and clinical course of urinary tract infections].
    Krzeska I; Ostojska J; Dzierzanowska D
    Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):706-9. PubMed ID: 1362812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the adhesion to catheters of uropathogenic Escherichia coli by sub-inhibitory concentrations of cefotaxime.
    Balagué C; Pérez J; Rinaudo M; Fernández L
    Eur J Obstet Gynecol Reprod Biol; 2011 Apr; 155(2):150-6. PubMed ID: 21277072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of host and bacterial virulence factors in the development of upper urinary tract infection caused by Escherichia coli.
    Tseng CC; Wu JJ; Liu HL; Sung JM; Huang JJ
    Am J Kidney Dis; 2002 Apr; 39(4):744-52. PubMed ID: 11920340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of fimbriae of Escherichia coli in urinary tract infections].
    Ishikawa S
    Hinyokika Kiyo; 1991 Sep; 37(9):953-6. PubMed ID: 1686148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virulence factors and O groups of Escherichia coli strains isolated from cultures of blood specimens from urosepsis and non-urosepsis patients.
    Blanco M; Blanco JE; Alonso MP; Blanco J
    Microbiologia; 1994 Sep; 10(3):249-56. PubMed ID: 7532950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some virulence characteristics of uropathogenic Escherichia coli in different patient groups.
    Naveen R; Mathai E
    Indian J Med Res; 2005 Aug; 122(2):143-7. PubMed ID: 16177472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunostimulation with Escherichia coli extract: prevention of recurrent urinary tract infections.
    Ha US; Cho YH
    Int J Antimicrob Agents; 2008 Feb; 31 Suppl 1():S63-7. PubMed ID: 17913471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do type 1 fimbriae promote inflammation in the human urinary tract?
    Bergsten G; Wullt B; Schembri MA; Leijonhufvud I; Svanborg C
    Cell Microbiol; 2007 Jul; 9(7):1766-81. PubMed ID: 17359236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
    Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
    J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of P fimbriae on pyuria and bacterial colonization of the human urinary tract].
    Wullt B; Bergsten G; Samuelsson M; Svanborg C
    Urologe A; 2003 Feb; 42(2):233-7. PubMed ID: 12607092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation changes as important factors for the susceptibility to urinary tract infection.
    Taganna J; de Boer AR; Wuhrer M; Bouckaert J
    Biochem Soc Trans; 2011 Jan; 39(1):349-54. PubMed ID: 21265802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli.
    Soto SM; Smithson A; Horcajada JP; Martinez JA; Mensa JP; Vila J
    Clin Microbiol Infect; 2006 Oct; 12(10):1034-6. PubMed ID: 16961644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Type 1 fimbriae, P fimbriae and X adhesins in Escherichia strains causing pyelonephritis, cystitis and recurrent urinary infections].
    Andreu A; Xercavins M; Fernández F
    Med Clin (Barc); 1989 Mar; 92(11):409-12. PubMed ID: 2566727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PapG-dependent adherence breaks mucosal inertia and triggers the innate host response.
    Bergsten G; Samuelsson M; Wullt B; Leijonhufvud I; Fischer H; Svanborg C
    J Infect Dis; 2004 May; 189(9):1734-42. PubMed ID: 15116313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [P-fimbriated Escherichia coli and serum antibody responses to P-fimbriae in pregnant women with urinary tract infections and their children].
    Miyazawa H; Yamaguchi M
    Nihon Jinzo Gakkai Shi; 1989 Mar; 31(3):293-9. PubMed ID: 2567787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Candidate vaccine against urinary tract infections].
    Hoepelman IM; Meiland R; Langermann S
    Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1860-2. PubMed ID: 11593791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of pili in the adhesion of Escherichia coli to human urinary tract epithelial cells.
    Korhonen TK; Väisänen V; Kallio P; Nurmiaho-Lassila EL; Ranta H; Siitonen A; Elo J; Svenson SB; Svanborg-Edén C
    Scand J Infect Dis Suppl; 1982; 33():26-31. PubMed ID: 6127801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between O serotype and virulent genes in Escherichia coli causing urinary tract infections.
    Emamghoraishi F; Farshad S; Kalani M
    Iran J Kidney Dis; 2011 Jul; 5(4):234-7. PubMed ID: 21725179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased predominance of papG class II allele in Escherichia coli strains isolated from adults with acute pyelonephritis and urinary tract abnormalities.
    Tseng CC; Huang JJ; Ko WC; Yan JJ; Wu JJ
    J Urol; 2001 Nov; 166(5):1643-6. PubMed ID: 11586193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.